Abstract
During the course of the Kefauver hearings, some testimony was given that presaged some important changes in the relationships between the pharmaceutical industry and organized pharmacy and individual pharmacists. The special nature of the drug marketplace–with the pharmacist as retailer i the channel of distribution–is discussed, along with the American Pharmaceutical Association's part in the Congressional hearings. Again, significant portions of the testimony in the various hearings are reproduced, along discussion and analysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Pharmaceutical Marketing & Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
